Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
10.99
0.09 (0.83%)
At close: Aug 15, 2025, 3:59 PM
11.01
0.18%
After-hours: Aug 15, 2025, 07:57 PM EDT

Intellia Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-101.25M -114.33M -128.9M -135.71M -146.97M -107.44M -132.16M -122.22M -123.68M -103.13M -113.41M -113.23M -100.68M -146.87M -81.24M -71.64M -68.81M -46.2M
Depreciation & Amortization
2.47M 2.5M 2.57M 2.61M 2.6M 2.51M 2.47M 2.29M 2.17M 2.05M 2.03M 1.95M 1.84M 1.75M 1.88M 1.79M 1.63M 1.59M
Stock-Based Compensation
22.04M 21.84M 39.62M 39.62M 40.86M 34.18M 35.04M 35.35M 36.4M 27.25M 24.63M 25.21M 23.07M 18.49M 14.56M 15.41M 10.61M 6.42M
Other Working Capital
-16.46M -54.93M 267K 12.02M 178K -35.33M 29.13M -8.79M -14.35M -36.93M -14.42M -16.64M -12.54M -17.74M -14.37M -5.81M -5.62M -5.56M
Other Non-Cash Items
-3.01M -155K -520K -1.29M 15.71M -20.19M -8.67M 968K 2.84M 1.39M 10.3M 10.68M 7.93M 64.39M 6.9M 2.1M 1.66M 1.21M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 7.16M -4.08M -3.08M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-19.87M -58.78M 2.04M 9.94M 29.62M -29.73M 3.11M -13.69M -4.97M -36.9M -13.42M -5.64M -17.24M -17.57M 3.25M -12.68M 1.92M -15.39M
Operating Cash Flow
-99.62M -148.93M -85.19M -84.84M -58.19M -120.66M -93.05M -101.38M -90.32M -109.33M -89.87M -78.53M -85.09M -79.8M -54.65M -65.02M -52.98M -52.38M
Capital Expenditures
-239K -735K -981K -1.28M -1.01M -2.51M -1.52M -4.33M -4.3M -3.83M -3.91M -4.24M -3.98M -46.26M -2.87M -4.54M -2.94M -2.41M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -47.46M -83.83M 30.24M 118.42M 56.24M n/a -99.33M n/a n/a n/a n/a n/a
Purchase of Investments
-55.6M -83.21M -169.1M -206.1M -300.81M -259.56M -149.78M -129.37M -243.29M -382.03M -236.43M -161.07M -31.52M n/a -247.86M -587.33M -37.1M -148.33M
Sales Maturities Of Investments
162.75M 178.27M 321.65M 178.71M 277.63M 267.96M 197.23M 213.2M 213.05M 263.62M 210.19M 212.8M 130.85M 93.73M 94.61M 192.49M 73.3M 125.2M
Other Investing Acitivies
n/a n/a n/a 20.97M n/a n/a 47.46M 83.83M -30.24M -118.42M -56.24M 51.88M 99.33M -44.83M -3M -394.84M 36.2M -23.13M
Investing Cash Flow
106.91M 94.33M 151.56M -7.71M -24.19M 5.9M 45.94M 79.5M -34.54M -122.25M -30.15M 47.64M 95.34M 47.47M -159.12M -399.38M 33.26M -25.54M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.24M n/a n/a 1.7M 2.85M 1.96M 2.87M 4.38M 2.52M 755K 2.11M 722K 5.89M 8.44M 2.28M 20.36M 7.13M 13.34M
Financial Cash Flow
14.65M n/a 2.32M 82.19M 41.25M 59.99M 106.48M 19.1M 2.52M 2.22M 505.76M 23.98M 5.89M 47.32M 2.28M 668.68M 7.13M 58.59M
Net Cash Flow
21.94M -54.6M 68.69M -10.35M -41.13M -54.77M 59.37M -2.78M -122.34M -229.35M 385.74M -6.91M 16.15M 14.99M -211.49M 204.28M -12.59M -19.32M
Free Cash Flow
-99.86M -149.66M -86.18M -86.12M -59.2M -123.17M -94.57M -105.71M -94.62M -113.16M -93.78M -82.76M -89.07M -126.06M -57.52M -69.56M -55.92M -54.79M